Oxybutynin Chloride

Product NDC: 0378-6610
11-digit product format: 003786610
Labeler code: 0378
Product ID: 0378-6610_c0c49bd6-f664-4d83-b04e-e3575e3492d6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: oxybutynin chloride
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: ANDA076644
Marketing category: ANDA
Marketing start: 2006-11-10
Marketing end: 2020-01-31
Substance: OXYBUTYNIN CHLORIDE
Active strength: 10 mg/1
Pharmacologic classes: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0378-6610		D	Discontinued by firm	2026-08-07
excluded package	package	0378-6610	0378-6610-01	D	Discontinued by firm	2026-08-07
excluded package	package	0378-6610	0378-6610-05	D	Discontinued by firm	2026-08-07

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-6610-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-6610-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-6610-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-6610-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-6610-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-6610-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-6610-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-6610-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-6610-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-6610-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-6610-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-6610-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-6610-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-6610-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-6610-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-6610-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-6610-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-6610-05	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-6610-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-6610-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-6610-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-6610-05	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-6610-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-6610-05	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076644-001	OXYBUTYNIN CHLORIDE	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL			2006-11-09
A076644-002	OXYBUTYNIN CHLORIDE	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL			2007-05-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2006-11-09	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL	AB	2007-05-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076644-001	OXYBUTYNIN CHLORIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2006-11-09	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076644-002	OXYBUTYNIN CHLORIDE	15MG	TABLET, EXTENDED RELEASE / ORAL		2007-05-10	`782e0a99824c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A076644-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076644-002	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A076644-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076644-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076644-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076644-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076644-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076644-002	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
3544f362-07fc-93b1-457b-1fba00be087a	Product name	8	20230316
4daffbf2-44c8-ca46-d284-5db69e1e6ef4	Product name	8	20210525
982338c6-c45c-b6b4-1452-14b01fbdf98d	Product name	2	20180801
054197ba-7ed3-0ddb-321e-dbb51c0fe9b6	Product name	2	20171212
3544f362-07fc-93b1-457b-1fba00be087a	Product name	2	20171212
8b00ae7e-01f2-f83c-632e-edfc23808364	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0378-6610-01	EA - Each	0378-6610	71040a67-4195-419c-96f6-7989de35174e	1	2012-07-24
0378-6610-05	EA - Each	0378-6610	f07f2ae1-a1a2-4125-b250-b3916bd9f187	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OXYBUTYNIN CHLORIDE	ACTIVE INGREDIENT	L9F3D9RENQ	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
OXYBUTYNIN	ACTIVE MOIETY	K9P6MC7092	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]	13
OXYBUTYNIN CHLORIDE	ACTIVE INGREDIENT	L9F3D9RENQ	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
OXYBUTYNIN	ACTIVE MOIETY	K9P6MC7092	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
METHYL ALCOHOL	INACTIVE INGREDIENT	Y4S76JWI15	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	5
OXYBUTYNIN CHLORIDE	ACTIVE INGREDIENT	L9F3D9RENQ	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
OXYBUTYNIN	ACTIVE MOIETY	K9P6MC7092	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MYLAN INSTITUTIONAL INC.]	3
OXYBUTYNIN CHLORIDE	ACTIVE INGREDIENT	L9F3D9RENQ	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
OXYBUTYNIN	ACTIVE MOIETY	K9P6MC7092	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
HYPROMELLOSE	INACTIVE INGREDIENT	3NXW29V3WO	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
METHYL ALCOHOL	INACTIVE INGREDIENT	Y4S76JWI15	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	OXYBUTYNIN CHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
L9F3D9RENQ	OXYBUTYNIN CHLORIDE	1508-65-2	OXYBUTYNIN CHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
863619	oxyBUTYnin chloride 10 MG 24HR Extended Release Oral Tablet	PSN	82c40f61-91a1-4946-b63f-0251aa01740c	1
863636	oxyBUTYnin chloride 5 MG 24HR Extended Release Oral Tablet	PSN	82c40f61-91a1-4946-b63f-0251aa01740c	1
863619	24 HR oxybutynin chloride 10 MG Extended Release Oral Tablet	SCD	82c40f61-91a1-4946-b63f-0251aa01740c	1
863636	24 HR oxybutynin chloride 5 MG Extended Release Oral Tablet	SCD	82c40f61-91a1-4946-b63f-0251aa01740c	1
863619	oxybutynin chloride 10 MG 24 HR Extended Release Oral Tablet	SY	82c40f61-91a1-4946-b63f-0251aa01740c	1
863636	oxybutynin chloride 5 MG 24 HR Extended Release Oral Tablet	SY	82c40f61-91a1-4946-b63f-0251aa01740c	1

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Oxybutynin Chloride	Mylan Institutional Inc.	2019-12-30	HUMAN PRESCRIPTION DRUG LABEL	7
Oxybutynin Chloride	NCS HealthCare of KY, Inc dba Vangard Labs	2019-11-15	HUMAN PRESCRIPTION DRUG LABEL	9
Oxybutynin Chloride	REMEDYREPACK INC.	2019-08-06	HUMAN PRESCRIPTION DRUG LABEL	3
Oxybutynin Chloride	Mylan Pharmaceuticals Inc.	2018-11-07	HUMAN PRESCRIPTION DRUG LABEL	18
Oxybutynin Chloride - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2010-01-21	HUMAN PRESCRIPTION DRUG LABEL	1